Kaplan-Meier analysis of clinical outcomes in critical COVID-19

Por um escritor misterioso
Last updated 19 novembro 2024
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Lung Ultrasound Score to Predict Outcomes in COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
IDCM — Infectious Diseases and Clinical Microbiology
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Cureus Clinical Outcomes of Early Versus Late Intubation in
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Trends in survival during the pandemic in patients with critical
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Cancer patient survival can be parametrized to improve trial
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
The efficiency and safety of high-dose vitamin C in patients with
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Trends in clinical characteristics and outcomes of all critically
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Critical care outcomes, for the first 200 patients with confirmed
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Evaluation of infliximab/tocilizumab versus tocilizumab among
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Epidemiology and outcomes of early-onset AKI in COVID-19-related

© 2014-2024 phtarkwa.com. All rights reserved.